Study Notes: Multiple Sclerosis and Myasthenia Gravis
Overview of Multiple Sclerosis (MS)
Definition: A chronic, progressive, and degenerative central nervous system (CNS) disorder characterized by the demyelination of nerve fibers in the brain and spinal cord.
Demographics: Onset typically occurs between ages . The condition is more likely to occur in women.
Disease Patterns: MS is marked by a remission and exacerbation pattern. The pace of progression is highly variable.
Pathophysiology and Manifestations of MS
Pathophysiology: Autoimmune T-cell activation leads to CNS inflammation and demyelination, which slows nerve impulses. This results in gliosis (plaque formation) and potentially irreversible axon damage in late stages.
Visual Symptoms: Includes nystagmus, diplopia, and blurred vision.
Motor and Sensory Symptoms: Weakness, spasticity, ataxia, intention tremors, and Lhermitte’s sign (electric shock-like sensations running down the back/limbs upon neck flexion).
Other Manifestations: Fatigue (major symptom), cognitive impairment, bowel/bladder dysfunction, and sexual dysfunction.
Diagnostic Criteria and Types of MS
Disease Types: * Relapsing-remitting (). * Primary-progressive (). * Secondary-progressive. * Progressive-relapsing ().
Diagnostic Tools: MRI is the test of choice to reveal MS lesions. Other tests include Lumbar Puncture (to check for or proteins) and Evoked Potential tests.
Clinical Diagnosis requirements: * Two or more episodes of exacerbation separated by and lasting more than . * History of exacerbations and remissions followed by progression over at least . * Slow, stepwise progression over at least .
MS Collaborative Care and Interventions
Drug Therapy Goals: Modify the disease process, treat acute exacerbations, and manage symptoms.
Nonpharmacologic Care: Includes Physical and Occupational Therapy (strengthening exercises, mobility aids) and counseling.
Self-Care Education: * Avoid triggers like infection, trauma, and stress. * Environmental control: Avoid extreme heat; use air conditioning or tepid baths. * Energy conservation: Rest to reduce fatigue.
Overview of Myasthenia Gravis (MG)
Definition: Meaning “grave muscle weakness,” MG is an autoimmune disease of the neuromuscular junction where antibodies destroy acetylcholine (ACh) receptors.
Characteristics: Skeletal muscle weakness that worsens with use throughout the day and improves with rest. It often originates in the face, neck, and jaw before affecting limbs.
Progression: Severity varies from mild motor disturbances to respiratory failure. Approximately half of patients present with vision problems.
Diagnosis and Clinical Manifestations of MG
Symptoms: Ptosis (drooping eyelids), diplopia, bulbar symptoms (chewing/swallowing/speech difficulty), and proximal limb weakness.
Bedside Tests: * Tensilon (Edrophonium) test: Acetylcholinesterase inhibitor that improves ptosis symptoms within . * Ice pack test: Placing ice on the eyelid for improves ptosis by enhancing transmission at lower temperatures.
Diagnostic Studies: Serologic tests for Acetylcholine receptor (AChR-Ab) and Muscle-specific tyramine kinase (MuSK) antibodies. Repetitive nerve stimulation (RNS) shows a progressive decline in response amplitude.
Management of Myasthenia Gravis
Short-Term Treatments: * Intravenous immunoglobulin (IVIG): Dials down the immune system's antibody production. * Plasmapheresis: Plasma exchange to remove antibodies (typically exchanges over a period).
Surgical Management: Thymectomy is often performed early (within of onset) because the thymus gland enhances AChR antibodies.
Nursing Care: Monitor respiratory status, time medications for peak effect during meals, and provide small, frequent, semi-solid meals to prevent aspiration.
Differentiating Myasthenic and Cholinergic Crises
Common Features: Restlessness, dyspnea, dysphagia, and respiratory failure.
Myasthenic Crisis: Caused by underdosing or infection. Symptoms improve with the Tensilon test. Features include and bowel/bladder incontinence.
Cholinergic Crisis: Caused by overdosing on anticholinesterase drugs. Symptoms worsen with the Tensilon test. Features include flaccid paralysis and hypersecretions (saliva, sweat, tears).